
STAT+: Doudna talks cost, access issues looming over first CRISPR therapy
“How do we make sure that a technology like CRISPR — you know, no offense intended — is not just going to make a few people rich, but it’s going… […]
“How do we make sure that a technology like CRISPR — you know, no offense intended — is not just going to make a few people rich, but it’s going… […]
What’s the future of Alzheimer’s disease treatment? How do you pivot from a pandemic? And how successful can Wegovy get? Find out on the new episode of “The Readout LOUD.” […]
Gilead’s CEO believes the foundation of the company will continue to be its HIV franchise, particularly PrEP. #STATBreakthrough […]
“Probably any words I use to describe my emotions at seeing this data will understate it,” said Daniel Skovronsky, Eli Lilly’s head scientist. […]
23AndMe CEO Anne Wojcicki was among the health data experts who convened to discuss the future of patient privacy at a panel this week. […]
23AndMe CEO Anne Wojcicki was among the health data experts who convened to discuss the future of patient privacy at a panel this week. […]
Copyright © 2023 Biotech Networks, LLC